Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2000
DOI: 10.1053/gast.2000.9114
|View full text |Cite
|
Sign up to set email alerts
|

Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
137
2
1

Year Published

2003
2003
2014
2014

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 206 publications
(147 citation statements)
references
References 39 publications
4
137
2
1
Order By: Relevance
“…␣-ManCer had been reported to have no agonist activity (14,35,36). Consistent with this result, we found that tetramers of ␣-ManCer͞CD1d did not stain V␣14i NKT cells, and ␣-ManCer only poorly stimulated V␣14i NKT cell hybridomas and did not cause IL-4 release in vivo.…”
Section: Discussionsupporting
confidence: 89%
“…␣-ManCer had been reported to have no agonist activity (14,35,36). Consistent with this result, we found that tetramers of ␣-ManCer͞CD1d did not stain V␣14i NKT cells, and ␣-ManCer only poorly stimulated V␣14i NKT cell hybridomas and did not cause IL-4 release in vivo.…”
Section: Discussionsupporting
confidence: 89%
“…A CD25 ϩ subset of these cells appears to suppress activity of colitigenic cells already deployed in the lamina propria (3,35,50). As noted above, other T cell subsets [intraepithelial CD8 ϩ (5, 6), CD4 ϩ CD8 ϩ (7, 9), or NKT (11,45) cells] also confer colitis resistance in some settings. At this juncture, it is not yet clear how B cell-dependent expansion of these central or mucosal T cell populations may reduce colitigenic CD4 ϩ T cell activity.…”
Section: Discussionmentioning
confidence: 88%
“…NKT cells in some settings suppress immune inflammation, including intraocular inflammation (15) and certain models of colitis (11,45). The mechanism for this protection is uncertain.…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, NKT cells have been implicated in a number of diverse immunological processes, including tumor responses, clearance of pathogens, regulation of autoimmunity, and tolerance induction (20 -23). Treatment with ␣-GalCer or ␣-GalCer-loaded dendritic cells (DC) induces a potent antitumor response by stimulating IFN-␥ production (24 -26), while ␣-GalCer has also been shown to ameliorate autoimmunity through the induction of Th2 responses (27)(28)(29). In contrast to the ability of ␣-GalCer to generate both Th1 and Th2 cytokines, OCH, a truncated derivative of ␣-GalCer, induces a preferential Th2 response that can suppress experimental autoimmune encephalitis and collagen-induced arthritis (30,31), whereas the C-glycoside derivative ␣-C-GalCer induces a selective Th1 response and is very effective at preventing tumor metastasis (32).…”
mentioning
confidence: 99%